Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new internal revision. This appears to be maintenance-only and does not reflect changes to the study information or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-27T06:17:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.3, indicating a new version of the page. This reflects a small administrative update to the page without changing the study details.
    Difference
    0.0%
    Check dated 2026-07-05T13:27:39.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study page gains new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that enrollment is closed, while the Intervention/Treatment header formatting is updated and the page revision is bumped to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T04:21:02.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.5) was added and the previous tag (v3.5.4) removed, signaling a recent deployment update of the page.
    Difference
    0.0%
    Check dated 2026-06-06T23:51:40.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.3 to v3.5.4, signaling a minor administrative update to the page version. No substantive content changes are introduced by this update.
    Difference
    0.0%
    Check dated 2026-05-16T10:09:41.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.